March 18, 2005





Eli Lilly and Company has decided that it will not abide by the statutory requirements of the PACE Program’s manufacturer’s rebate mandate.


Accordingly, effective Monday, June 13, 2005, the Commonwealth will no longer be able to reimburse for any Eli Lilly products for PACE, PACENET, CRDP, SPBP, Cystic Fibrosis, Spina Bifida, PKU or MSUD.


Questions concerning this action may be directed to:


Gino Santini

Senior Vice President, Corporate Strategy and Policy

Eli Lilly and Company

Lilly Corporate Center

Indianapolis, Indiana 46285

Telephone 317-277-9301


With PACE no longer permitted to reimburse for Lilly pharmaceuticals, concerned prescribers, providers or caregivers of cardholders in need of Lilly products are encouraged to contact LillyAnswers, a patient assistance program for low-income individuals. Applications can be obtained by calling 1-877-795-4559 (toll-free) or visiting their website at .